Back to Journals » Drug Design, Development and Therapy » Volume 9
Review
A perspective on the benefit-risk assessment for new and emerging pharmaceuticals in Japan
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
13,804 | Dovepress* | 11,086+ | 1,935 | 13,021 | |
PubMed Central* | 2,718 | 483 | 3,201 | ||
Totals | 13,804 | 2,418 | 16,222 | ||
*Since 31 March 2015 +Since July 2016 |
View citations on PubMed Central and Google Scholar